Tian Ruixiang Hldgs Ltd Stock Price, News & Analysis

TIAN RUIXIANG Holdings (Nasdaq: TIRX) entered a definitive agreement to acquire BEYOND COASTLINE HOLDINGS LIMITED, issuing 7,200,000 Class A ordinary shares at $2 per share (approx. $14.4M consideration). Closing is anticipated on or about November 5, 2025.

The Target is a Southeast Asian new-retail group focused on brand operation, e-commerce, offline retail, cosmetics import/logistics and social commerce, with partnerships across KOL/KOC networks and a management team with cross-border e-commerce experience. TRX says the deal supports its Southeast Asia expansion and integration of the Target’s consumer ecosystem into TRX’s digital insurance services.

TIAN RUIXIANG Holdings (Nasdaq: TIRX) entered into a definitive agreement to acquire REN Talents Inc. by issuing 3,211,010 Class A ordinary shares at $2.18 per share (implied consideration ≈ $7,000,001.80). The transaction is anticipated to close on or about November 5, 2025 or such other date as agreed.

REN Talents is a full-service creative brand agency with offices in New York, Shanghai and Paris, serving 100+ cross-industry clients (fashion, technology, retail) and managing international talent including Maggie Q. TRX positions the deal as part of a globalization strategy to expand U.S. and European consumer and branding capabilities and to integrate insurance services into a proposed "Insurance + Brand + Lifestyle" ecosystem.

TIAN RUIXIANG Holdings (Nasdaq: TIRX) priced a registered direct offering to institutional investors for 2,000,000 Class A ordinary shares and warrants to purchase up to 4,000,000 additional Class A ordinary shares at a combined purchase price of $1.50 per share and accompanying warrant, generating gross proceeds of approximately $3.0 million.

The warrants are exercisable immediately at an exercise price of $1.50 and expire five years after initial exercise. Closing is expected on or about October 14, 2025, subject to customary conditions. Net proceeds are intended for working capital and general corporate purposes. The offering is made under an effective Form F-3 registration statement (File No. 333-269348); a final prospectus supplement will be filed with the SEC.

TIAN RUIXIANG Holdings (Nasdaq: TIRX) has announced a 5-to-1 reverse stock split effective September 5, 2025. The company's shares will continue trading on the Nasdaq Capital Market under the same ticker symbol TIRX.

As part of this corporate action, the par value of both Class A and Class B ordinary shares will increase from US$0.025 to US$0.125 per share. Any fractional shares resulting from the split will be rounded up to the nearest whole share. The company's Class A ordinary shares will receive a new CUSIP number: G8884K 136.

[]

TIAN RUIXIANG Holdings (NASDAQ:TIRX) has completed the acquisition of Ucare Inc. in an all-stock transaction valued at $150 million. The deal involves issuing 101,486,575 Class A ordinary shares at $0.025 par value per share.

Ucare operates China's only cloud-based AI-driven hospital and health insurance risk management platform, serving over 4,000 hospitals. The acquisition strategically positions TRX at the intersection of healthcare and insurance, with plans to integrate Ucare's generative AI technology into TRX's health insurance workflows for improved fraud detection, operational efficiency, and pricing accuracy.

The merger aims to create an integrated insurance-hospital ecosystem, with Ucare leveraging TRX's platform, capital resources, and strategic relationships to advance R&D and expand its AI capabilities. The combined entity will focus on developing innovative healthcare solutions and expanding business channels while enhancing transparency and efficiency in health insurance services.

TIAN RUIXIANG Holdings (TIRX) announced plans to acquire Ucare Inc., China's only cloud-based AI-driven hospital and health insurance risk management platform, in an all-stock deal valued at $150 million. The acquisition involves issuing 101,486,575 new Class A ordinary shares at $1.478 per share, representing 91.75% of TIRX's total Class A shares and 13.70% of voting power. Ucare serves over 4,000 hospitals and has helped reduce healthcare expenditures by $6.82 billion. In FY2024, Ucare reported $0.6M net profit on $5.4M revenue. The deal, expected to close in July 2025, includes an escrow condition tied to Ucare achieving RMB150 million cumulative revenue over three years. This strategic acquisition aims to enhance TIRX's health insurance offerings, leveraging Ucare's AI technology and hospital network to create a unified healthcare ecosystem.

TIAN RUIXIANG Holdings (Nasdaq: TIRX), a China-based insurance broker, reported financial results for the half year ended April 30, 2024. The company faced a net loss of $2.6 million, primarily due to a significant revenue decline of 75.4% to $0.2 million. This decrease was mainly attributed to the loss of key insurance company partners. Despite challenges, the company saw an increase in commissions from liability insurance. Total operating expenses rose by 18.4% to $3.1 million. The company is pursuing strategies to mitigate losses, including expanding into the Hong Kong insurance brokerage market and diversifying its client base.

TIAN RUIXIANG Holdings (Nasdaq: TIRX), a China-based insurance broker, has regained compliance with Nasdaq's periodic filing requirement. The company received written notification from Nasdaq on July 18, 2024, confirming its compliance with Listing Rule 5250(c)(1). This follows the company's filing of its annual report on Form 20-F for the period ended October 31, 2023, which was submitted on July 17, 2024. The announcement marks an important step for TIRX in maintaining its listing status on the Nasdaq Stock Market.

TIAN RUIXIANG Holdings (Nasdaq: TIRX) reported financial results for the fiscal year ended October 31, 2023. The company, a China-based insurance broker, experienced an 8.0% decrease in revenue to $1.2 million, primarily due to lower commissions from several insurance products and loss of certain partners. However, they achieved a significant increase of $612,000 in commissions from liability insurance products. Despite the revenue decline, TIRX managed to reduce its net loss by 47.6% to $2.5 million, down from $4.7 million in the previous year. This improvement demonstrates enhanced financial performance and operational efficiency. The company's total operating expenses decreased by 33.6% to $4.3 million, while the loss from operations narrowed by 40.5% to $3.0 million.